FDA Adverse Event Injury Summary report: N

IROX

MDR report key: 5623196 · Received May 1, 2016

Report

Report Number
2124215-2016-02536
Event Type
Injury
Date Received
May 1, 2016
Date of Event
January 14, 2016
Report Date
January 14, 2016
Manufacturer
GUIDANT ANGLETON/ST. PAUL
Product Code
DTB
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT WITH THIS PRODUCT DEVELOPED AN INFECTION. A SYSTEM EXTRACTION WAS SCHEDULED. HOWEVER, DUE TO PATIENT'S AGE THE PHYSICIAN BELIEVED THAT THE EXTRACTION PROCEDURE WAS NOT WARRANTED AND MEDICAL MANAGEMENT WAS THE SAFER COURSE OF ACTION. THERE WERE NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED. ALL AVAILABLE INFORMATION INDICATES THAT THE PRODUCT REMAINS IN SERVICE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
278333 IROX IMPLANTABLE LEAD DTB GUIDANT ANGLETON/ST. PAUL 430-07

Patients

Seq Age Sex Outcome Treatment
1 94 YR Life Threatening| R